Author:
Cen Yanyan,Li Xiaoli,Liu Dan,Pan Feng,Cai Yongqing,Li Bin,Peng Wei,Wu Chong,Jiang Weiwei,Zhou Hong
Funder
Major Scientific and Technological Special Project
Subject
Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry
Reference30 articles.
1. CpG oligodeoxynucleotides as immunotherapy in cancer;Jahrsdorfer;Cancer Ther.,2008
2. G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice;Gekeler;Oligonucleotides,2006
3. Immune-mediated tumor regression induced by CpG-containing oligodeoxynucleotides;Baines;Cancer Res.,2003
4. CpG oligodeoxynucleotides as TLR9 agonists: therapeutic applications in cancer;Murad;BioDrugs,2009
5. X.L. Li, D. Liu, X. Liu, W.W. Jiang, W.Y. Zhou, W. Yan, CpG ODN107 potentiates radiosensitivity of human glioma cells via TLR9-mediated NF-κB activation and NO production. Tumor Biol., http://dx.doi.org/10.1007/s13277-012-0416-1, in press.
Cited by
19 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献